These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, Lee SS, Seo DW, Lee SK. Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454 [Abstract] [Full Text] [Related]
25. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging. Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F. J Hepatobiliary Pancreat Surg; 2004 May; 11(5):310-8. PubMed ID: 15549429 [Abstract] [Full Text] [Related]
31. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma. Kim HM, Park JY, Kim KS, Park MS, Kim MJ, Park YN, Bang S, Song SY, Chung JB, Park SW. J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880 [Abstract] [Full Text] [Related]
33. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. Park HS, Lee JM, Choi JY, Lee MW, Kim HJ, Han JK, Choi BI. AJR Am J Roentgenol; 2008 Feb; 190(2):396-405. PubMed ID: 18212225 [Abstract] [Full Text] [Related]